Recently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development ...

For buy-side firms, Bloomberg AIM delivers global, multi-asset solutions for portfolio management, trading, compliance and operations. AIM is designed to offer the most scalable asset management ...

Compared to similar products using the mRNA technology route, AIM's mRNA shingles vaccine also ... creating favourable conditions for entry into the global market, which is projected to reach ...